- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01076712
Effectiveness of Physiotherapy Interventions for Patients With Parkinson's Disease
March 9, 2010 updated by: Queen Elizabeth Hospital, Hong Kong
The Effectiveness of Physiotherapy Interventions in Patients With Parkinson's Disease, a Randomized Controlled Trial
Parkinson's Disease is an incurable and progressive disease.
Treatment includes medication and non-pharmacological intervention such as physiotherapy.
Physiotherapy is a main component of non-pharmacological interventions.
It includes exercise to strengthen the muscles; improves balance and walking, and adopts the use of visual cue training.
Treatment has been found to be effective in patients with mild impairment up to 6 months post-treatment.
The present study will investigate the effectiveness of treatment for patients with mild to moderate impairment for short term (3-month) and long term (1 year).
The hypothesis is that compared to patient education alone, physiotherapy intervention for patients with Parkinson's disease leads to improve function and quality of life.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Parkinson's disease (PD) is an incurable and progressive disease (Rubenis 2007).
Current management include medical, neuro-surgical and non-pharmacological intervention.
Physiotherapy is a major component in non-pharmacological interventions.
Effective interventions including visual or auditory cues improves gait (Nieuwboer et al. 2007), exercise is effective in improving balance (Hirsch et al 2003); intense treadmill training improves motor control, quality of life and walking speed so as to sustain improvement in gait speed and motor control post 4 weeks of treatment (Herman et al 2007).
Patient with PD attending physiotherapy twice weekly, one and half hour for 12 weeks showed improvement in walking speed and Activities of Daily Living (Ellis et al 2005).
However, the majority of focus on patients in the Hoehn and Yahr stage of 2 to 3 and long term effect is lacking (Kwakkel et al 2007).
A knowledge gap is present in the effectiveness of physiotherapy training of patients with Parkinson's disease in the more advanced stage of disease and long term effect is lacking.
The aim of the study is to investigate the immediate, short-term & long-term clinical effects of physiotherapy training of patients with Parkinson's disease.
The hypothesis is that compared to patient education alone, physiotherapy intervention for patients with Parkinson's disease leads to improve function and quality of life.
Study Type
Interventional
Enrollment (Anticipated)
112
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kowloon, Hong Kong
- Recruiting
- Queen Elizabeth Hospital
-
Contact:
- CW Woo
- Phone Number: 29586218
- Email: woocw@ha.org.hk
-
Sub-Investigator:
- YF Cheung, Dr
-
Sub-Investigator:
- HF Chan, Dr
-
Sub-Investigator:
- HM Chan, Dr
-
Sub-Investigator:
- MY Lau, Dr
-
Sub-Investigator:
- HS Chan
-
Sub-Investigator:
- HF Mak
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Stable medication usage
- Hoehn and Yahr stage II to IV
- At least 1 score of 2 or more for at least 1 limb of either the tremor, rigidity, or bradykinesia item of the Unified Parkinson's Disease Rating Scale (UPDRS)
- Able to walk independently
- No severe cognitive impairments (Mini-Mental State Examination - Chinese Cantonese version) score greater than 24
Exclusion Criteria:
- Other severe neurological, cardiopulmonary, or orthopedic disorders
- Having participated in a physiotherapy or rehabilitation program in previous 2 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Physiotherapy Interventions
Physiotherapy Interventions including strengthening exercise, balance training, gait training with visual cue, gait training with treadmill.
|
Physiotherapy interventions including strengthening exercise, balance training, gait training with visual cus and gait training with treadmill
|
Other: Education
|
Education Classes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Movement Disorder Society-Unified Parkinson's Disease Rating Scale
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Levodopa equivalent daily dosage (LEDD)
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Timed Up and Go Test
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
|
Activities-Specific Balance Confidence Scale (Chinese version)
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
|
Parkinson's Disease Questionnaire (Standard Chinese Version)
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Parkinson's Disease Questionnaire (Standard Chinese Version) - PDQ-39 (Chinese)
|
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Number of Injurious Falls
Time Frame: Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Baseline. Immediate, 3-month, 6-month and 1 year Post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: CW WOO, Physiotherapy Department, Queen Elizabeth Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Herman T, Giladi N, Gruendlinger L, Hausdorff JM. Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study. Arch Phys Med Rehabil. 2007 Sep;88(9):1154-8. doi: 10.1016/j.apmr.2007.05.015.
- Nieuwboer A, Kwakkel G, Rochester L, Jones D, van Wegen E, Willems AM, Chavret F, Hetherington V, Baker K, Lim I. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry. 2007 Feb;78(2):134-40. doi: 10.1136/jnnp.200X.097923. Erratum In: J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1414. J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):126.
- Hirsch MA, Toole T, Maitland CG, Rider RA. The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson's disease. Arch Phys Med Rehabil. 2003 Aug;84(8):1109-17. doi: 10.1016/s0003-9993(03)00046-7.
- Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340.
- Morris S, Morris ME, Iansek R. Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease. Phys Ther. 2001 Feb;81(2):810-8. doi: 10.1093/ptj/81.2.810.
- Mak MK, Lau AL, Law FS, Cheung CC, Wong IS. Validation of the Chinese translated Activities-Specific Balance Confidence scale. Arch Phys Med Rehabil. 2007 Apr;88(4):496-503. doi: 10.1016/j.apmr.2007.01.018.
- Tsang KL, Chi I, Ho SL, Lou VW, Lee TM, Chu LW. Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson's disease. Mov Disord. 2002 Sep;17(5):1036-40. doi: 10.1002/mds.10249.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Anticipated)
October 1, 2012
Study Completion (Anticipated)
October 1, 2012
Study Registration Dates
First Submitted
February 25, 2010
First Submitted That Met QC Criteria
February 25, 2010
First Posted (Estimate)
February 26, 2010
Study Record Updates
Last Update Posted (Estimate)
March 10, 2010
Last Update Submitted That Met QC Criteria
March 9, 2010
Last Verified
March 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KCKESOP0016a
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Physiotherapy Interventions
-
North District HospitalRecruitingChronic Obstructive Pulmonary DiseaseHong Kong
-
Sheffield Children's NHS Foundation TrustUniversity of SheffieldCompletedDysfunctional BreathingUnited Kingdom
-
International Food Policy Research InstituteFHI 360; Addis Continental Institute of Public HealthCompletedDietary DiversityUnited States
-
Boston Medical CenterNational Center for Complementary and Integrative Health (NCCIH)Enrolling by invitation
-
International Food Policy Research InstituteFHI 360; Addis Continental Institute of Public HealthCompletedMaternal Dietary Diversity | Iron-Folic Acid Supplementation | Early Initiation of BreastfeedingUnited States
-
Universiti Putra MalaysiaRecruiting
-
SimpleC, LLCUniversity of Georgia; Advanced Medical ElectronicsCompletedQuality of Life | Cognitive Impairment | Dementia | Cognitive Change | Mild Cognitive Impairment | Engagement, Patient | Mood | Aging WellUnited States
-
University of GenovaNot yet recruiting
-
Hacettepe UniversityCompleted
-
Akdeniz UniversityCompleted